(Q47292504)

13 January 2018

title

Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease (English)

1 reference

13 January 2018

mild cognitive impairment

main subject

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

3

Elliott J Mufson

1 reference

13 January 2018

author name string

Shiyong Peng

series ordinal

1

1 reference

13 January 2018

Joanne Wuu

series ordinal

2

1 reference

13 January 2018

Margaret Fahnestock

series ordinal

4

1 reference

13 January 2018

publication date

1 June 2004

1 reference

13 January 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

13 January 2018

volume

63

1 reference

13 January 2018

issue

6

1 reference

13 January 2018

page(s)

641-649

1 reference

13 January 2018

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Challenging the cholinergic hypothesis in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Nerve growth factor selectively increases cholinergic markers but not neuropeptides in rat basal forebrain in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Morphological response of axotomized septal neurons to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Natural history of mild cognitive impairment in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Rapid isolation of the 7S-nerve growth factor complex and its subunits from murine submaxillary glands and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

The apolipoprotein E epsilon 2 allele and decline in episodic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Characterization of nerve growth factor precursor protein expression in rat round spermatids and the trophic effects of nerve growth factor in the maintenance of Sertoli cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Study of cytoskeletal proteins in fibroblasts cultured from familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Apolipoprotein E, synaptic plasticity and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Entorhinal lesions result in increased nerve growth factor-like growth-promoting activity in medium conditioned by hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Plasticity of hippocampal circuitry in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Synaptic Rearrangement in the Dentate Gyrus: Histochemical Evidence of Adjustments after Lesions in Immature and Adult Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Nerve growth factor signaling, neuroprotection, and neural repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Nerve growth factor: biosynthetic products of the mouse salivary glands. Characterization of stable high molecular weight and 32,000-dalton nerve growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

ProNGF: a neurotrophic or an apoptotic molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Regulation of cell survival by secreted proneurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Neurotrophin signalling pathways regulating neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Neurotrophins: to cleave or not to cleave

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

Region-Specific Neurotrophin Imbalances in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.6.641

21 January 2018

Identifiers

DOI

10.1093/JNEN/63.6.641

1 reference

13 January 2018

1 reference

13 January 2018